Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Hyperkeratosis

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    105 result(s) found for: Hyperkeratosis. Displaying page 1 of 6.
    1  2  3  4  5  6  Next»
    EudraCT Number: 2007-005795-13 Sponsor Protocol Number: Ketoil 01/07 Start Date*: 2007-11-12
    Sponsor Name:MIPHARM
    Full Title: EFFICACY AND SAFETY ASSESSMENT OF KETOIL, SHAMPOO CONTAINING KETOCONAZOLE 0.5% SERENOA REPENS (SAW PALM) AND TAURINE, IN THE TREATMENT OF PATIENTS AFFECTED BY DANDRUFF AND SEBORRHEIC DERMATITIS COM...
    Medical condition: dandruff and seborroic dermatitis
    Disease: Version SOC Term Classification Code Term Level
    6.1 10050909 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-000066-29 Sponsor Protocol Number: RD.03.SPR.114384 Start Date*: 2017-05-15
    Sponsor Name:Galderma R&D
    Full Title: Subject reported outcomes on satisfaction, efficacy and safety with Luxerm® in the field-directed treatment of thin or non-hyperkeratotic and non-pigmented Actinic Keratosis of the face or the scalp
    Medical condition: Thin or non-hyperkeratotic and non-pigmented Actinic Keratosis on the face and scalp
    Disease: Version SOC Term Classification Code Term Level
    19.1 100000004858 10020648 Hyperkeratoses HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2018-000545-39 Sponsor Protocol Number: DERMAQ-001 Start Date*: 2018-04-30
    Sponsor Name:ASL 1 AVEZZANO-SULMONA-L'AQUILA
    Full Title: A randomized half-side comparative study of Methyl aminolevulinate (MAL, Metvix®) Daylight photodynamic therapy (DL-PDT) with or without pre-treatment with calcitriol (Silkis®) for Actinic Keratosi...
    Medical condition: Actinic Keratosis
    Disease: Version SOC Term Classification Code Term Level
    21.0 100000004858 10020648 Hyperkeratoses HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-000973-54 Sponsor Protocol Number: RD.03.SPR.29112 Start Date*: 2013-06-04
    Sponsor Name:Galderma R&D SNC
    Full Title: Multi-centre, randomized, investigator-blind, intra-individual active and vehicle-controlled study, comparing Metvix® Natural Daylight Photodynamic Therapy versus Metvix® conventional Photodynamic ...
    Medical condition: Mild and/or moderate Actinic Keratoses
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004858 10020648 Hyperkeratoses HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed) DE (Completed) NL (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2006-005034-20 Sponsor Protocol Number: 228-13/06 Start Date*: 2007-03-08
    Sponsor Name:Klinik für Dermatologie und Venerologie, Universitätsklinikum Hamburg-Eppendorf
    Full Title: Doppelblinde, prospektiv-randomisierte, intraindividuell-halbseitenvergleichende Studie zur klinischen Wirksamkeit von Verrumal® Lsg. bei aktinischen Keratosen gegen Vehikel: Investigator-initiiert...
    Medical condition: Actinic keratosis is a precancerous skin growth usually caused by sun exposure. Symptoms: Rough and dry textured skin lesion, macule, patch, or growth on the skin Located on sun-exposed areas. Acti...
    Disease: Version SOC Term Classification Code Term Level
    8.1 10000614 Actinic keratosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-005171-14 Sponsor Protocol Number: Start Date*: 2008-01-07
    Sponsor Name:NHS Tayside
    Full Title: A Randomised Double Blind Comparative Study of Pain During and After MAL or 5-ALA Photodynamic Therapy
    Medical condition: Bowen's disease (sqaumous cell carcinoma in-situ) and actinic keratoses
    Disease: Version SOC Term Classification Code Term Level
    9.1 10000614 Actinic keratosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-000093-23 Sponsor Protocol Number: H 565000 - 0620 Start Date*: 2007-05-18
    Sponsor Name:Almirall Hermal GmbH
    Full Title: Clinical trial to investigate clinical efficacy and tolerability of Tretinoin in actinic keratosis
    Medical condition: actinic keratosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10000614 Actinic keratosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2015-003020-31 Sponsor Protocol Number: 24-08-2015version3.0 Start Date*: 2015-09-03
    Sponsor Name:Department of Dermatology, Bispebjerg University Hospital
    Full Title: Pulse-Daylight-Photodynamic Therapy of Actinic Keratoses
    Medical condition: Actinic keratoses
    Disease: Version SOC Term Classification Code Term Level
    18.1 100000004858 10041304 Solar keratosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-005525-33 Sponsor Protocol Number: HDP 606 Start Date*: 2007-03-21
    Sponsor Name:Heidelberg Pharma GmbH
    Full Title: A Multi-Centre Double-Blind Randomised Placebo-Controlled Phase II Study of HDP 99.0006 in Patients with Actinic Keratosis
    Medical condition: Actinic Keratosis are scaling epidermal lesions, which consist of dysplastic keratinocytes. They mostly appear in pale-skinned patients which are chronically overexposed to UV radiation. Actinic ke...
    Disease: Version SOC Term Classification Code Term Level
    8.1 10000614 Actinic keratosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-002108-15 Sponsor Protocol Number: no_nbr Start Date*: 2013-06-05
    Sponsor Name:Mari Grönroos
    Full Title: Treating actinic keratoses with natural daylight PDT: comparing two light sensitizers (ALA vs. MAL)
    Medical condition: actinic keratoses of the face or scalp
    Disease: Version SOC Term Classification Code Term Level
    16.0 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Elderly Gender: Male, Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-001701-33 Sponsor Protocol Number: 58161 Start Date*: 2017-05-19
    Sponsor Name:Department of Dermatology D92, Bispebjerg Hospital
    Full Title: Photodynamic therapy without curettage
    Medical condition: Actinic keratosis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2014-002756-11 Sponsor Protocol Number: 43739 Start Date*: 2014-08-27
    Sponsor Name:Department of Dermatology D92, Bispebjerg Hospital
    Full Title: Photodynamic therapy with varying application times for treatment of actinic keratosis
    Medical condition: Actinic keratosis
    Disease: Version SOC Term Classification Code Term Level
    17.0 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-005432-24 Sponsor Protocol Number: H 10056002-0615 Start Date*: 2007-03-09
    Sponsor Name:Hermal Kurt Herrmann GmbH & Co OHG
    Full Title: Clinical trial to investigate clinical efficacy and tolerability of Verrumal in actinic keratosis (PoC)
    Medical condition: actinic keratosis
    Disease: Version SOC Term Classification Code Term Level
    8.1 10000614 Actinic keratosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2010-022502-40 Sponsor Protocol Number: PLES-AK-P-4/12/10 Start Date*: 2010-10-28
    Sponsor Name:Pantec Biosolution AG
    Full Title: Prospektive, randomisierte, klinische 4-Arm Pilotstudie zur Dosisfin-dung der kombinierten Anwendung von P.L.E.A.S.E. mit 5% topischen Imiquimod versus Standardapplikation von 5% topischem Imiquim...
    Medical condition: Actinic Keratosis
    Disease: Version SOC Term Classification Code Term Level
    12.1 10000614 Actinic keratosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-002501-39 Sponsor Protocol Number: 201073 Start Date*: 2009-02-06
    Sponsor Name:MedaPharma
    Full Title: Quality of life of patients with actinic keratoses and/or a superficial basal cell carcinoma treated with Imiquimod 5% cream.
    Medical condition: patients with actinic keratoses and/or a superficial basal cell carcinoma
    Disease: Version SOC Term Classification Code Term Level
    9.1 10042503 Superficial basal cell carcinoma LLT
    9.1 10000614 Actinic keratosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-003003-29 Sponsor Protocol Number: 49301 Start Date*: 2015-08-31
    Sponsor Name:Department of Dermatology D92, Bispebjerg Hospital
    Full Title: 5-flourouracil treatment prior to photodynamic therapy of actinic keratosis on the hands
    Medical condition: Actinic keratosis
    Disease: Version SOC Term Classification Code Term Level
    18.0 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2016-005084-14 Sponsor Protocol Number: 56297 Start Date*: 2017-01-23
    Sponsor Name:Deoartment of Dermatology D92, Bispbjerg Hospital
    Full Title: PpIX in curetted and non-curetted skin after Metvix application
    Medical condition: Actinic keratosis
    Disease: Version SOC Term Classification Code Term Level
    19.0 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2017-000228-85 Sponsor Protocol Number: LP0084-1369 Start Date*: 2017-05-30
    Sponsor Name:LEO Pharma A/S
    Full Title: Incidence of squamous cell carcinoma and other skin neoplasia in subjects with actinic keratosis treated with ingenol disoxate gel 0.018% or 0.037%, or vehicle A phase 3 trial to compare the inc...
    Medical condition: Actinic Keratosis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended) DE (Prematurely Ended) ES (Prematurely Ended) IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2021-005996-37 Sponsor Protocol Number: JAZ-02 Start Date*: 2022-01-18
    Sponsor Name:Zealand University Hospital
    Full Title: Gene and protein expression profiles after treatment of actinic keratosis
    Medical condition: Actinic keratoses
    Disease: Version SOC Term Classification Code Term Level
    20.0 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2020-003316-27 Sponsor Protocol Number: 12020 Start Date*: 2021-04-01
    Sponsor Name:Medical University of Graz
    Full Title: Earliest Stage Treatment of Actinic Keratosis with Imiquimod 3.75% Cream
    Medical condition: Actintic keratosis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  5  6  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat May 03 21:14:35 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA